171 related articles for article (PubMed ID: 24004513)
1. Primary neuroendocrine carcinoma breast: our experience.
Suhani ; Ali S; Desai G; Thomas S; Aggarwal L; Meena K; Kumar J; Jain M; Tudu SK
Breast Dis; 2014; 34(3):95-9. PubMed ID: 24004513
[TBL] [Abstract][Full Text] [Related]
2. Paget's disease of the breast: the experience of the European Institute of Oncology and review of the literature.
Caliskan M; Gatti G; Sosnovskikh I; Rotmensz N; Botteri E; Musmeci S; Rosali dos Santos G; Viale G; Luini A
Breast Cancer Res Treat; 2008 Dec; 112(3):513-21. PubMed ID: 18240020
[TBL] [Abstract][Full Text] [Related]
3. A rare breast tumor: solid neuroendocrine carcinoma.
Sanguinetti A; Santoprete S; Lucchini R; Triola R; Loreti F; Avenia N
Ann Ital Chir; 2013; 84(1):81-5. PubMed ID: 22672972
[TBL] [Abstract][Full Text] [Related]
4. [Clinicopathological features and prognostic factors of breast cancer patients with inguinal lymph node metastases: a report of 17 cases].
Li Q; Xu BH; Zhang P; Li Q; Yuan P; Wang JY; Luo Y; Ma F; Fan Y; Li Q
Zhonghua Zhong Liu Za Zhi; 2013 Mar; 35(3):207-11. PubMed ID: 23880002
[TBL] [Abstract][Full Text] [Related]
5. Changes in management techniques and patterns of disease recurrence over time in patients with breast carcinoma treated with breast-conserving therapy at a single institution.
Pass H; Vicini FA; Kestin LL; Goldstein NS; Decker D; Pettinga J; Ingold J; Benitez P; Neumann K; Rebner M; Dekhne N; Martinez A
Cancer; 2004 Aug; 101(4):713-20. PubMed ID: 15305400
[TBL] [Abstract][Full Text] [Related]
6. Frequency of HER-2/neu receptor positivity and its association with other features of breast cancer.
Naeem M; Nasir A; Aman Z; Ahmad T; Samad A
J Ayub Med Coll Abbottabad; 2008; 20(3):23-6. PubMed ID: 19610508
[TBL] [Abstract][Full Text] [Related]
7. Spectrum of neuroendocrine carcinomas of the uterine cervix, including histopathologic features, terminology, immunohistochemical profile, and clinical outcomes in a series of 50 cases from a single institution in India.
Rekhi B; Patil B; Deodhar KK; Maheshwari A; A Kerkar R; Gupta S; Tongaonkar HB; Shrivastava SK
Ann Diagn Pathol; 2013 Feb; 17(1):1-9. PubMed ID: 22534245
[TBL] [Abstract][Full Text] [Related]
8. Effective role of hormonal therapy in metastatic primary neuroendocrine breast carcinoma.
Buttar A; Mittal K; Khan A; Bathini V
Clin Breast Cancer; 2011 Oct; 11(5):342-5. PubMed ID: 21729664
[TBL] [Abstract][Full Text] [Related]
9. [Clinical features and prognosis of 25 cases of breast carcinosarcoma].
Yang YF; Liu J; Fang ZY; Gu L
Zhonghua Zhong Liu Za Zhi; 2012 Aug; 34(8):620-3. PubMed ID: 23158999
[TBL] [Abstract][Full Text] [Related]
10. Neuroendocrine carcinomas of the breast.
Rovera F; Masciocchi P; Coglitore A; La Rosa S; Dionigi G; Marelli M; Boni L; Dionigi R
Int J Surg; 2008; 6 Suppl 1():S113-5. PubMed ID: 19167937
[TBL] [Abstract][Full Text] [Related]
11. Low risk of locoregional recurrence of primary breast carcinoma after treatment with a modification of the Halsted radical mastectomy and selective use of radiotherapy.
Bijker N; Rutgers EJ; Peterse JL; van Dongen JA; Hart AA; Borger JH; Kroon BB
Cancer; 1999 Apr; 85(8):1773-81. PubMed ID: 10223572
[TBL] [Abstract][Full Text] [Related]
12. Postoperative loco-regional radiation therapy for breast cancer patients with four or more involved lymph nodes or extracapsular extension.
Evron E; Barzily L; Rakowsky E; Ben-Baruch N; Sulkes J; Rizel S; Fenig E
Isr Med Assoc J; 2005 Jul; 7(7):439-42. PubMed ID: 16011059
[TBL] [Abstract][Full Text] [Related]
13. Solid neuroendocrine breast carcinomas: incidence, clinico-pathological features and immunohistochemical profiling.
López-Bonet E; Alonso-Ruano M; Barraza G; Vazquez-Martin A; Bernadó L; Menendez JA
Oncol Rep; 2008 Dec; 20(6):1369-74. PubMed ID: 19020716
[TBL] [Abstract][Full Text] [Related]
14. Management of neuroendocrine carcinomas of the breast: A rare entity.
Yildirim Y; Elagoz S; Koyuncu A; Aydin C; Karadayi K
Oncol Lett; 2011 Sep; 2(5):887-890. PubMed ID: 22866145
[TBL] [Abstract][Full Text] [Related]
15. Primary neuroendocrine carcinoma of the breast A single Center experience and review of the literature.
Locurto P; Antona AD; Grillo A; Ciulla A; Martorana S; Cipolla C; Graceffa G; Vieni S
Ann Ital Chir; 2016 Nov; 87():. PubMed ID: 27905324
[TBL] [Abstract][Full Text] [Related]
16. Survival benefit of post-mastectomy radiotherapy in breast carcinoma patients with T1-2 tumor and 1-3 axillary lymph node(s) metastasis.
Duraker N; Demir D; Bati B; Yilmaz BD; Bati Y; Çaynak ZC; Sobutay E
Jpn J Clin Oncol; 2012 Jul; 42(7):601-8. PubMed ID: 22511807
[TBL] [Abstract][Full Text] [Related]
17. Clinical features and treatment response of solid neuroendocrine breast carcinoma to adjuvant chemotherapy and endocrine therapy.
Zhu Y; Li Q; Gao J; He Z; Sun R; Shen G; Zhang H; Xia W; Xu J
Breast J; 2013; 19(4):382-7. PubMed ID: 23721399
[TBL] [Abstract][Full Text] [Related]
18. HER-2 positive primary solid neuroendocrine carcinoma of the breast: a case report and review of the literature.
Yavas G; Karabagli P; Araz M; Yavas C; Ata O
Breast Cancer; 2015 Jul; 22(4):432-6. PubMed ID: 22711316
[TBL] [Abstract][Full Text] [Related]
19. The carcinoembryonic antigen as a potential prognostic marker for neuroendocrine carcinoma of the breast.
Su CH; Chang H; Chen CJ; Liu LC; Wang HC; Lane HY; Bau DT
Anticancer Res; 2012 Jan; 32(1):183-8. PubMed ID: 22213305
[TBL] [Abstract][Full Text] [Related]
20. The association between biological subtype and locoregional recurrence in newly diagnosed breast cancer.
Gabos Z; Thoms J; Ghosh S; Hanson J; Deschênes J; Sabri S; Abdulkarim B
Breast Cancer Res Treat; 2010 Nov; 124(1):187-94. PubMed ID: 20814819
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]